Danielle Lo, MD
Ophthalmology · Hacienda Heights, CANPI 1164878948
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 400 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations.
Across 400 payments — averaging $24.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$1K
- Alcon$1K
- AbbVie$1K
- Sun Pharmaceutical Industries Inc.$1K
- Amgen$697
- Sight Sciences, Inc.$688
- plus $3K from 24 others
What the payments were for
- Food & beverage$9,776100%
- Gifts$190%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 42 | $1,396 |
| Alcon | 61 | $1,394 |
| AbbVie(2 entities) | 62 | $1,382 |
| Sun Pharmaceutical Industries Inc. | 61 | $1,267 |
| Amgen(2 entities) | 29 | $697 |
| Sight Sciences, Inc. | 14 | $688 |
| Aerie Pharmaceuticals, Inc. | 31 | $483 |
| Oyster Point Pharma, Inc. | 14 | $299 |
| Ivantis, Inc | 3 | $288 |
| Johnson & Johnson Surgical Vision, Inc. | 8 | $253 |
| Dompe US, Inc. | 7 | $177 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 10 | $163 |
| Novartis | 9 | $153 |
| Kala Pharmaceuticals, Inc. | 8 | $141 |
| Mallinckrodt Hospital Products Inc. | 6 | $139 |
| Tarsus Pharmaceuticals, Inc. | 5 | $137 |
| Harrow Eye, LLC | 5 | $135 |
| Eyevance Pharmaceuticals LLC | 6 | $112 |
| Beaver-visitec International, Inc. | 1 | $98 |
| Thea Pharma Inc. | 4 | $81 |
| ANI Pharmaceuticals, Inc. | 3 | $70 |
| Merz Pharmaceuticals, LLC | 2 | $59 |
| Coopervision Inc. | 2 | $48 |
| Apellis Pharmaceuticals, Inc. | 1 | $26 |
| Ocular Therapeutix, Inc. | 1 | $21 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Akorn, Inc. | 1 | $18 |
| Biotissue Holdings Inc. | 1 | $18 |
| Rxsight Inc | 1 | $18 |
| Nova Eye, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,796 in reported general payments places this provider in the 85th percentile of 2,513 ophthalmology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Hacienda Heights
- Daniel SchwartzSan Francisco$8M
- Michael BerlinWest Hollywood$5.7M
- Gilbert KlimanMenlo Park$1.5M
- Kuldev SinghStanford$1.5M
- Raymond DouglasBeverly Hills$1.3M
- John AffeldtLoma Linda$1.1M
- Srinivas SaddaPasadena$1M
- Sheri RowenNewport Beach$1M
- Savak TeymoorianLaguna Hills$955K
- Andrew MoshfeghiLos Angeles$895K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.